Contrarily, positive expression of ASGR in CECs was more frequent in LC (42.9%; 18/42) than in HCC without prior LC (22.2%; 2/9), suggesting that LC patients (independently on their cancer status) were more likely to have ASGR1 positive CECs (Figure 5B). Here, ASGR1 is linked to hepatocellular carcinoma.